Loading...
Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS)
PURPOSE: Autoimmune lymphoproliferative syndrome (ALPS) is a non-malignant genetic disorder of lymphocyte homeostasis with defective Fas-mediated apoptosis. Current therapies for ALPS primarily target autoimmune manifestations with non-specific immune suppressants with variable success thus highligh...
Na minha lista:
| Udgivet i: | J Clin Immunol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7780245/ https://ncbi.nlm.nih.gov/pubmed/26453583 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10875-015-0203-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|